SignatureFD’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49K Hold
102
﹤0.01% 3197
2026
Q1
$757 Buy
102
+68
+200% +$716 ﹤0.01% 3259
2025
Q4
$400 Hold
34
﹤0.01% 3256
2025
Q3
$262 Hold
34
﹤0.01% 3255
2025
Q2
$249 Sell
34
-100
-75% -$807 ﹤0.01% 3168
2025
Q1
$1.27K Hold
134
﹤0.01% 2991
2024
Q4
$2.21K Hold
134
﹤0.01% 2842
2024
Q3
$1.98K Sell
134
-1,500
-92% -$23.5K ﹤0.01% 2834
2024
Q2
$22.7K Hold
1,634
﹤0.01% 1900
2024
Q1
$25.7K Hold
1,634
﹤0.01% 1874
2023
Q4
$26.4K Hold
1,634
﹤0.01% 1785
2023
Q3
$20.1K Hold
1,634
﹤0.01% 1848
2023
Q2
$26.3K Sell
1,634
-40
-2% -$659 ﹤0.01% 1755
2023
Q1
$29.1K Sell
1,674
-151
-8% -$2.15K ﹤0.01% 1663
2022
Q4
$16.9K Sell
1,825
-71
-4% -$662 ﹤0.01% 1890
2022
Q3
$16K Buy
1,896
+1,669
+735% +$16.6K ﹤0.01% 1863
2022
Q2
$2K Sell
227
-407
-64% -$3.89K ﹤0.01% 2776
2022
Q1
$8K Buy
634
+477
+304% +$10K ﹤0.01% 2271
2021
Q4
$5K Sell
157
-13
-8% -$509 ﹤0.01% 2403
2021
Q3
$8K Buy
170
+43
+34% +$1.99K ﹤0.01% 2185
2021
Q2
$6K Sell
127
-32
-20% -$1.42K ﹤0.01% 2220
2021
Q1
$8K Buy
159
+32
+25% +$1.67K ﹤0.01% 1958
2020
Q4
$7K Buy
127
+113
+807% +$5.11K ﹤0.01% 1841
2020
Q3
$1K Buy
+14
New +$520 ﹤0.01% 2463

Other funds holding NEO

SignatureFD's NEO Position: Q2 2026 in Review

SignatureFD held its NeoGenomics (NEO) position steady in Q2 2026 at 102 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #3197.

SignatureFD first reported a position in NEO in Q3 2020 and has held it in 24 quarters since. The position peaked at $29.1K in Q1 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • SignatureFD held 102 shares of NeoGenomics worth $1.49K as of Q2 2026.
  • SignatureFD left its NeoGenomics share count unchanged in Q2 2026.
  • NeoGenomics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3197 holding.
  • SignatureFD first reported a position in NeoGenomics in Q3 2020 and has held it in 24 quarters since.
  • SignatureFD's NeoGenomics position peaked at $29.1K in Q1 2023.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.